A cost analysis of first-line chemotherapy for low-risk gestational trophoblastic neoplasia
The Journal of Reproductive Medicine,  Clinical Article

Shah NT et al. – Based on similar efficacy and lower societal cost, authors recommend 8–day MTX/folinic acid for first–line treatment of low–risk gestational trophoblastic neoplasia (GTN).

Methods
  • A decision tree of the 3 most commonly used first–line low–risk GTN treatment strategies was created, accounting for toxicities, response rates and need for second– or third–line therapy.
  • These strategies included 8–day methotrexate (MTX)/folinic acid, weekly MTX, and pulsed actinomycin–D (act–D).
  • Response rates, average number of cycles needed for remission, and toxicities were determined by review of the literature.
  • Costs of each strategy were examined from a societal perspective, including the direct total treatment costs as well as the indirect lost labor production costs from work absences.
  • Sensitivity analysis on these costs was performed using both deterministic and probabilistic cost–minimization models with the aid of decision tree software (TreeAge Pro 2011, TreeAge Inc., Williamstown, Massachusetts).

Results
  • They found that 8–day MTX/folinic acid is the least expensive to society, followed by pulsed act–D ($4,867 vs. $6,111 average societal cost per cure, respectively), with act–D becoming more favorable only with act–D per–cycle cost <$231, or response rate to first–line therapy >99%.
  • Weekly MTX is the most expensive first–line treatment strategy to society ($9,089 average cost per cure), despite being least expensive to administer per cycle, based on lower first–line response rate.
  • Absolute societal cost of each strategy is driven by the probability of needing expensive third–line multiagent chemotherapy, however relative cost differences are robust to sensitivity analysis over the reported range of cycle number and response rate for all therapies.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Obstetrics & Gynecology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

<

Most Popular Obstetrics & Gynecology Articles

1 Candy twists as an alternative to the glucola beverage in gestational diabetes mellitus screening American Journal of Obstetrics and Gynecology, December 5, 2014    Clinical Article

2 Common cholesterol-fighting drug may prevent hysterectomies in women with uterine fibroids University of Texas Medical Branch at Galveston, November 14, 2014

3 Vitamin D and pregnancy outcomes Current Opinion in Obstetrics and Gynecology, November 14, 2014    Review Article

4 Diet-induced weight loss has chronic tissue-specific effects on glucocorticoid metabolism in overweight postmenopausal women International Journal of Obesity, December 8, 2014    Clinical Article

5 Diabetic pregnancy: An overview of current guidelines and clinical practice Current Opinion in Obstetrics and Gynecology, November 21, 2014    Review Article

6 Vitamin D status in early pregnancy and risk of preeclampsia (E14-0363) American Journal of Obstetrics and Gynecology, November 26, 2014    Clinical Article

7 Association between labetalol use for hypertension in pregnancy and adverse infant outcomes European Journal of Obstetrics & Gynecology and Reproductive Biology, February 17, 2014    Clinical Article

8 Relationship between preeclampsia and vitamin D deficiency: A case control study Archives of Gynecology and Obstetrics, December 17, 2014    Clinical Article

9 Risk of stroke in healthy postmenopausal women during and after hormone therapy: A meta-analysis Menopause, November 11, 2014    Clinical Article

10 Vitamin D deficiency among adolescent females with polycystic ovary syndrome Journal of Pediatric and Adolescent Gynecology , December 16, 2014    Review Article

11 Peripheral nerve blocks in the treatment of migraine in pregnancy Obstetrics and Gynecology, December 4, 2014    Review Article

12 Abortion surveillance - United States, 2011 Full Text Morbidity and Mortality Weekly Report, December 1, 2014    Free full text

13 Pathologic findings at risk-reducing salpingo-oophorectomy: Primary Results From Gynecologic Oncology Group Trial GOG-0199 Journal of Clinical Oncology, September 19, 2014    Clinical Article

14 Effects of physical exercise on health-related quality of life and blood lipids in perimenopausal women: A randomized placebo-controlled trial Menopause, December 11, 2014    Clinical Article

15 Womens age at first menstrual cycle linked to heart disease risk American Heart Association News, December 16, 2014

16 Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: A secondary analysis of the MFMU High-Risk Aspirin Study Journal of Perinatology, December 5, 2014    Clinical Article

17 A prospective cohort study of dietary indices and incidence of epithelial ovarian cancer Full Text Journal of Ovarian Research, December 19, 2014    Free full text    Clinical Article

18 Effect of ginger (Zingiber officinale) on heavy menstrual bleeding: a placebo-controlled, randomized clinical trial Phytotherapy Research, October 13, 2014    Clinical Article

19 Immediate compared with delayed cord clamping in the preterm neonate: a randomized controlled trial Obstetrics and Gynecology, December 1, 2014    Evidence Based Medicine    Clinical Article

20 Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: A systematic review BJOG: An International Journal of Obstetrics and Gynaecology, June 5, 2014    Evidence Based Medicine    Review Article

Indexed Journals in Obstetrics & Gynecology: Obstetrics and Gynecology, American Journal of Obstetrics and Gynecologymore

Make smarter career moves with less time.

Sign up for our free job placement service today and have a dedicated career consultant help locate the right physician job for you!
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.
 

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List